News brief
On 2026-07-26, according to Xiniu Data, Shengqiang Technology completed Series C financing for an undisclosed amount. Investors were Zhaoshangju Capital, Shenzhen Danbao Group. The company is a provider of integrated digital intelligent pathology solutions.
Connected profiles
Explore
Sources · 0Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
2026年7月26日，据烯牛数据报道，生强科技完成C轮融资，金额未披露。投资方为招商局资本，深圳担保集团。该公司为数字智慧病理一体化解决方案提供商。